A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/6352278

Download in:

View as

General Info

PMID
6352278